Larimar Therapeutics Inc (LRMR)
7.61
+0.26
(+3.54%)
USD |
NASDAQ |
May 02, 16:00
7.605
0.00 (0.00%)
After-Hours: 20:00
Larimar Therapeutics 1 Year Total Returns (Daily): 67.25% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | 67.25% |
May 01, 2024 | 58.06% |
April 30, 2024 | 45.67% |
April 29, 2024 | 39.75% |
April 26, 2024 | 42.48% |
April 25, 2024 | 40.35% |
April 24, 2024 | 43.56% |
April 23, 2024 | 43.56% |
April 22, 2024 | 42.22% |
April 19, 2024 | 32.72% |
April 18, 2024 | 35.74% |
April 17, 2024 | 51.61% |
April 16, 2024 | 59.82% |
April 15, 2024 | 61.15% |
April 12, 2024 | 53.64% |
April 11, 2024 | 58.68% |
April 10, 2024 | 53.71% |
April 09, 2024 | 57.49% |
April 08, 2024 | 61.52% |
April 05, 2024 | 70.25% |
April 04, 2024 | 66.36% |
April 03, 2024 | 69.67% |
April 02, 2024 | 62.47% |
April 01, 2024 | 64.68% |
March 28, 2024 | 72.50% |
Date | Value |
---|---|
March 27, 2024 | 63.26% |
March 26, 2024 | 60.36% |
March 25, 2024 | 68.82% |
March 22, 2024 | 86.41% |
March 21, 2024 | 80.21% |
March 20, 2024 | 76.60% |
March 19, 2024 | 59.67% |
March 18, 2024 | 55.20% |
March 15, 2024 | 50.26% |
March 14, 2024 | 47.37% |
March 13, 2024 | 62.30% |
March 12, 2024 | 59.17% |
March 11, 2024 | 56.62% |
March 08, 2024 | 67.76% |
March 07, 2024 | 84.15% |
March 06, 2024 | 88.91% |
March 05, 2024 | 83.71% |
March 04, 2024 | 82.43% |
March 01, 2024 | 95.02% |
February 29, 2024 | 89.77% |
February 28, 2024 | 89.77% |
February 27, 2024 | 86.35% |
February 26, 2024 | 99.20% |
February 23, 2024 | 94.23% |
February 22, 2024 | 88.71% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.06%
Minimum
Sep 26 2019
160.7%
Maximum
Dec 07 2020
-17.07%
Average
-28.32%
Median
Feb 14 2023
1 Year Total Returns (Daily) Benchmarks
Cogent Biosciences Inc | -32.19% |
ACADIA Pharmaceuticals Inc | -20.16% |
PTC Therapeutics Inc | -38.84% |
Renovaro Inc | 22.95% |
G1 Therapeutics Inc | 49.49% |